Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28378626 | 0.77 | MGAM (0.39) | TSHRALDH1A1 | |
| SCHEMBL9419778 | 0.74 | — | — | |
| SCHEMBL9419775 | 0.74 | FFAR3 (0.33) | FFAR3TSHREGLN1ALDH1A1 | |
| SCHEMBL6889837 | 0.74 | TET2 (0.35) | — | |
| SCHEMBL30497716 | 0.72 | ALDH1A1 (0.40) | TSHRALDH1A1 | |
| SCHEMBL10946037 | 0.72 | ALDH1A1 (0.38) | TSHRALDH1A1LMNA | |
| SCHEMBL1093452 | 0.72 | FFAR3 (0.38) | FFAR3EGLN1ALDH1A1HDAC3HDAC1 | |
| SCHEMBL909260 | 0.72 | TSHR (0.41) | FFAR3TSHREGLN1ALDH1A1HDAC3 | |
| Potassium Ion SCHEMBL3912677 | 0.72 | FFAR3 (0.32) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL15364753 | 0.71 | FNTA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591631-A | Siloxane-based amide secondary amine chain extender, and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-1333083-C | Substrate fixing physiologically substance and its preparation | SAMSUNG SDI CO LTD (KR) | 2007-08-22 | — | — | CN | claimed |
| US-7097882-B2 | Substrate for immobilizing physiological material, and method of fabricating same | SAMSUNG SDI CO., LTD. (KR) | 2006-08-29 | — | — | US | claimed |
| US-20030129740-A1 | Method of preparing substrate having functional group pattern for immobilizing physiological material | SAMSUNG SDI CO., LTD. (KR) | 2003-07-10 | — | — | US | claimed |
| US-20030072951-A1 | Substrate for immobilizing physiological material, and method of fabricating same | SAMSUNG SDI CO., LTD. (KR) | 2003-04-17 | — | — | US | claimed |
| CN-1407116-A | Substrate fixing physiologically substance and its preparation | SAMSUNG SDI CO LTD (KR) | 2003-04-02 | — | — | CN | claimed |
| EP-1291655-A2 | Substrate for immobilizing physiological material and method of fabricating same | Samsung SDI Co., Ltd. (KR) | 2003-03-12 | — | — | EP | claimed |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4692941-A2 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| CN-119591631-A | Siloxane-based amide secondary amine chain extender, and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-108333869-B | Photosensitive composition, cured film, method for producing same, and display element, light-emitting element, and light-receiving element | JSR株式会社 | 2023-07-18 | — | — | CN | disclosed |
| EP-1666535-B1 | RESIN COMPOSITION AND COMPOSITE USING THE COMPOSITION AND PRODUCTION PROCESS THEREOF | DAICEL EVONIK LTD (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-8697375-B2 | In vivo biofilm infection diagnosis and treatment | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-04-15 | — | — | US | disclosed |
| US-6117543-A | Reactive particles and process for the production thereof | KRI INTERNATIONAL, INC. (JP) | 2000-09-12 | — | — | US | disclosed |
| US-5942320-A | COMPRISING BASE FILM LAYER, ANCHOR COAT LAYER, INORGANIC LAYER AND BARRIER RESIN LAYER CONTAINING SILANE COUPLING AGENT; PRESERVING DRIED FOODS, PACKAGING USE IN PHARMACEUTICAL AND ELECTRONICS INDUSTRIES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-08-24 | — | — | US | disclosed |
| EP-0885937-A1 | REACTIVE PARTICLES AND PROCESS FOR THE PRODUCTION THEREOF | KRI International, Inc. (JP) | 1998-12-23 | — | — | EP | disclosed |
| EP-0829507-A2 | Barrier composite films and a method for producing the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| CN-1176173-A | Barrier composite films and method for producing the same | DAICEL CHEM (JP) | 1998-03-18 | — | — | CN | disclosed |
| EP-0011456-B1 | ORGANOTIN COMPOUNDS AND RESINS OR POLYMERS STABILIZED THEREWITH | M & T CHEMICALS, INC. (US) | 1983-09-07 | — | — | EP | disclosed |
| US-4254017-A | HEAT STABILIZER FOR POLYVINYL CHLORIDE | M&T CHEMICALS INC. (US) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SMC1A, SPOUT1, LBR | FFAR3 110/4885TSHR 446/4885EGLN1 1989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.